Načítá se...
(89)Zr-Onartuzumab PET imaging of c-MET receptor dynamics
PURPOSE: c-MET and its ligand hepatocyte growth factor are often dysregulated in human cancers. Dynamic changes in c-MET expression occur and might predict drug efficacy or emergence of resistance. Noninvasive visualization of c-MET dynamics could therefore potentially guide c-MET-directed therapies...
Uloženo v:
| Vydáno v: | Eur J Nucl Med Mol Imaging |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486818/ https://ncbi.nlm.nih.gov/pubmed/28315949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3672-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|